Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Ran20
    Junior Member
    • Jun 2021
    • 1

    #1

    Using R package to implement Bayesian phase I/II dose-finding design for three outcom

    Dear all,

    I am trying to implement the work done by Suyu Liu, "A Bayesian Phase I/II Trial Design for Immunotherapy", using R, since the code attached with that work takes a lot of time (more than 20 hours, and the code not complete). So that I tried to use trialr package since it used rstan, but this package allowed me to use two outcomes ( toxicity, efficacy ) and the work of Liu used three outcomes (immune response, toxicity, and efficacy).

    I tried to use the R package trialr for two outcomes using the utility for sensitivity analysis written in R code below (table 1 in the article), I want to see if I used the correct utility and to see how to add a third outcome ( immune response ) to the model

    and thanks in advance.

    Here is the work of Liu:

    https://www.tandfonline.com/doi/supp...260?scroll=top

    ````

    ### My code###
    rm(list = ls())
    library(trialr)

    #Utility
    Uti <- array(0,c(2,3,2)) # order: tox, eff, immuno
    Uti[,,1] <- matrix(c(0,0,50,10,80,35),nrow=2)
    Uti[,,2] <- matrix(c(5,0,70,20,100,45),nrow=2)
    N.max= 60 # patients
    outcomes <- '1NNN 2NNT 3NNT 4NNN 5NTN'
    doses = c(.1,.3,.5,.7,.9)


    fit <- stan_efftox(outcomes,
    real_doses =doses,
    efficacy_hurdle = 0.5, toxicity_hurdle = 0.3,
    p_e = 0.1, p_t = 0.1,
    eff0 = 0.5, tox1 = 0.65,
    eff_star = 0.7, tox_star = 0.25,
    alpha_mean = -7.9593, alpha_sd = 3.5487,
    beta_mean = 1.5482, beta_sd = 3.5018,
    gamma_mean = 0.7367, gamma_sd = 2.5423,
    zeta_mean = 3.4181, zeta_sd = 2.4406,
    eta_mean = 0, eta_sd = 0.2,
    psi_mean = 0, psi_sd = 1,
    seed = 123)

    ndoses <- length(fit$prob_tox)
    plot(1:ndoses, fit$prob_tox, type="b", pch=19, xlab="Dose level", ylab="Probability of toxicity", ylim=c(0,max(fit$prob_tox) + 0.15), col="green")
    points(1:ndoses,fit$prob_eff, type="b", pch=18, col="blue")
    abline(h=0.3, lwd=2, lty=4, col = "red")
    legend(1, 0.4, legend=c("Toxicity", "Effecacy"),
    col=c("green", "blue"), lty=1:2, cex=0.8)

    ````
  • monicall89
    Junior Member
    • Jun 2021
    • 2

    #2
    Thank you so much for this information; it’s really a very good information and very authentic and useful information for us. I really appreciate you have share this information.
    If you know more about this information just click here ptcl speed test and check more information with more reasonable and authentic way.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...